Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 2Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 5Genitourinary 2CNS 2Thoracic 1Other hematologic neoplasm 1Other 1Lymphoid 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 2260Lung Neoplasms 1048Small Cell Lung Carcinoma 402Adenocarcinoma of Lung 154Mesothelioma, Malignant 120Breast Neoplasms 110Neoplasms 106Brain Neoplasms 101Neoplasm Metastasis 95Melanoma 72Mesothelioma 70NSCLC 68Colorectal Neoplasms 68Adenocarcinoma, Bronchiolo-Alveolar 56Thymoma 53Pancreatic Neoplasms 52Ovarian Neoplasms 46Head and Neck Neoplasms 46Carcinoma, Renal Cell 43Carcinoma 38Stomach Neoplasms 36Sarcoma 35Prostatic Neoplasms 35Esophageal Neoplasms 34Adenocarcinoma 34Uterine Cervical Neoplasms 33Squamous Cell Carcinoma of Head and Neck 33Pleural Effusion, Malignant 33Recurrence 27Urinary Bladder Neoplasms 26

Interventions

cytisine 1Spirometry 1Hematologic Tests 1Diet Therapy 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Inflammation × Thoracic × Clear all
NCT03654105 2026-03-27

SMILE

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Active not recruiting
2,000 enrolled
Thoracic

Inflammation, Lung Neoplasms, Motor Activity, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡